When a QC analyst in Singapore encountered lower-than-expected recovery while Filtering a small-volume protein-containing sample before chromatography, the immediate suspicion was an instrument fault. A recent, non-validated material change made the loss visible within one sequence; a review showed that membrane, format, and process selection—not a defective filter or failed instrument—needed attention.
Summary: An Rc Syringe Filter is often considered when a hydrophilic membrane and low nonspecific binding are needed, but recovery must be qualified with the actual sample matrix. A 13mm Syringe Filter is a small-volume format choice; pore size and membrane material are separate decisions. As a product-page specification, regenerated-cellulose disc formats at 13 mm are listed at 0.22 and 0.45 µm, while the RC membrane range also includes 0.1, 0.8, and 1.0 µm. Define recovery, hold-up, and particulate-control acceptance criteria before changing either membrane or housing format.
Why an Rc Syringe Filter needs matrix-specific recovery qualification
Regenerated cellulose (RC) is a hydrophilic membrane material. That property can make it a practical candidate for aqueous, protein-containing preparations where nonspecific interaction is a concern; it does not, by itself, establish a recovery result for every protein, buffer, concentration, or contact time. The useful question is not whether a material is described as low binding in general, but whether a defined method retains the analyte response after the filtration step.
For an Rc Syringe Filter evaluation, compare an unfiltered control with a filtered aliquot at the intended concentration. Include at least three independently prepared aliquots per condition as an illustrative minimum for a screening study, then predefine the assay response and acceptance limit. This is a qualification design, not a universal performance claim. For sterile-process applications, the FDA’s aseptic-processing guidance treats filtration validation as process-specific, with the fluid, filter, and operating conditions considered together.
Hidden cost begins when a superficially inexpensive consumable creates repeat injections, investigations, or delayed release decisions. An illustrative calculation is simple: if a 10-sample batch requires one repeat sequence after a recovery discrepancy, the cost includes analyst time, instrument time, standards, and schedule risk—not only ten filters. Qualification records that identify the matrix, pore size, lot, device format, and test response make that cost visible before purchasing is scaled.
Design a recovery check that can be repeated
Use the final preparation sequence, not an idealized water-only challenge, whenever the method contains salts, organic modifier, surfactant, preservative, or a protein mixture. Record the sample volume loaded, discard practice if any, filtration pressure approach, time from filtration to analysis, and the chromatographic response. These factors create a traceable baseline if a later procurement decision changes the membrane, device format, or supplier documentation.
Screening can begin at the reportable concentration and, where the method has a range, at a second concentration near the lower end. The numerical design should be justified by the laboratory’s method procedure and data-quality requirements. A laboratory that cannot distinguish filtration loss from assay variability has not yet established a usable comparison; adding more filters without a control does not solve that information gap.
How a 13mm Syringe Filter affects small-volume filtration
A 13mm Syringe Filter is commonly selected where the available sample volume is limited and a compact filtration area is appropriate. It should not be read as a promise of a particular recovery, throughput, or dead-volume result. Those outcomes depend on housing design, membrane, sample viscosity, particulate loading, wetting behavior, and the operating method.
Microlab’s RC membrane product page lists 13 mm disc formats at 0.22 and 0.45 µm. Those two values are format-specific product-page information; they do not mean that every RC syringe device is available in both configurations. In a method-development plan, use the stated pore size as the particulate-control target, then compare a small-volume device with the actual transfer and recovery workflow.
| Decision point | RC membrane consideration | 13 mm format consideration | TCO implication |
|---|---|---|---|
| Primary purpose | Hydrophilic material; qualify analyte recovery | Small-volume handling | Reduces avoidable rework when matched to the method |
| Pore-size example | Product page lists 0.1, 0.22, 0.45, 0.8, and 1.0 µm | Listed 13 mm discs: 0.22 and 0.45 µm | Choose particulate control before judging unit cost |
| Evidence needed | Filtered-versus-control assay comparison | Transfer, hold-up, and handling check | Prevents a low purchase price from becoming repeat testing |
ASTM F838 is a bacterial-retention test-method reference for membrane filters under defined challenge conditions; it is not blanket certification of an Rc Syringe Filter, and it does not substitute for analyte-recovery testing. Its relevance rises only when the intended use and claimed filtration function require a microbiological retention study. Keep that study distinct from routine particulate clarification work.
Small-format selection also changes the operational conversation. Check whether the device is intended to process one analytical aliquot at a time or whether the laboratory expects multiple transfers from a prepared vial. If a process contains visible particulate, a preclarification step or a different pore-size choice may be more appropriate than forcing the compact filter to do two jobs. The appropriate answer follows the validated method, rather than a nominal diameter alone.
How Rc Syringe Filter selection links membrane, pore size, and total cost
Pore size answers a different question from membrane chemistry. A 0.22 µm option is often evaluated when fine particulate control is required, while a 0.45 µm option may be appropriate for less restrictive clarification; neither number establishes suitability without the sample and downstream method. The same RC product-page range includes 0.1, 0.8, and 1.0 µm, which reinforces why buyers should specify the desired retention objective rather than request RC alone.
ASTM D543 is a standard test-method reference for evaluating the resistance of plastics to chemical reagents. It is not a blanket product certification, and it should not be used to claim compatibility for a specific Rc Syringe Filter without applicable material, exposure, temperature, time, and performance data. A procurement specification should therefore separate membrane compatibility, housing compatibility, and analytical recovery evidence.
| Application situation | Selection question | Useful verification | Decision risk |
|---|---|---|---|
| Protein-containing analytical sample | Does the filtered aliquot meet the pre-set recovery criterion? | Assay comparison at intended concentration | Unrecognized analyte loss |
| Small-volume preparation | Does a 13mm Syringe Filter fit the transfer and sample-volume workflow? | Replicate handling and recovery check | Loss to handling or hold-up |
| Particulate clarification | Which pore size meets the method objective? | Visual, analytical, or method-defined particulate assessment | Unnecessary restriction or inadequate cleanup |
| Aseptic-process claim | Is a process-specific validation needed? | Documented validation strategy aligned to intended use | Unsupported microbiological claim |
The purchase specification should also record a change-control trigger. A change from one membrane or device format to another is not a like-for-like substitution merely because the nominal pore size stays at 0.22 µm. Treat the added qualification work, potential out-of-specification review, and downstream delay as part of the decision’s total cost of ownership.
Separate device questions from membrane questions
A clear request for quotation distinguishes four fields: membrane material, nominal pore size, device diameter or format, and evidence required for the intended method. This avoids a common sourcing failure in which a quotation meets one field—such as a 0.45 µm rating—but leaves material or housing details unclear. It also helps distributors compare technically similar options without representing an unverified substitution as equivalent.
Where solvent exposure or cleaning agents are relevant, define the concentration, temperature, and exposure duration. ASTM D543 provides a structured reference for evaluating plastics against chemical reagents, but the test plan must cover the materials and conditions actually at issue. A broad compatibility statement without those conditions offers little protection against a failed batch or an unsupported customer claim.
How a 13mm Syringe Filter fits compliance documentation
For regulated pharmaceutical work, the applicable obligation depends on the intended process and market. In the United States, 21 CFR Part 211 includes requirements for written procedures, component controls, laboratory records, and investigations under current good manufacturing practice. It does not turn a generic 13mm Syringe Filter into a compliant finished process by itself; the user’s documented method, supplier controls, and change management remain central.
For a process described as sterile or aseptic, distinguish a method reference from a certification claim. ASTM F838 may inform bacterial-retention testing, and the FDA guidance addresses aseptic processing expectations, but neither source automatically certifies a specific product. Similarly, ASTM D543 may support a material-resistance test plan; it is not proof that every solvent exposure is acceptable. Claims should be limited to evidence that has actually been generated and reviewed.
Documentation should state whether filtration is used for clarification, analytical sample preparation, or a microbiological control function. These are materially different intended uses. For example, a 0.22 µm nominal pore-size notation may be important to a laboratory’s procedure, but it should not be promoted as a sterilizing claim unless the relevant validation evidence and regulatory context support that statement. The commercial consequence of imprecise wording is often a costly investigation or delayed customer approval.
How to select an Rc Syringe Filter from Microlab Scientific
Start procurement with four actions: define the matrix and analyte; select the pore-size objective; decide whether a compact 13 mm format matches sample handling; and request the documentation needed for the destination market and intended claim. For a routine method, retain a reference sample and record the test conditions so a future supply change can be assessed without reconstructing the investigation.
Microlab Scientific supplies laboratory-filtration consumables and filtering solutions, including syringe filters and multiple membrane materials. Its supplied company certification is ISO 9001:2015; that is a company quality-management certification, not a product certification. Buyers can use the site’s syringe filter guides as a starting point, then obtain configuration and qualification details appropriate to their method.
Frequently asked questions
What is an RC membrane?
RC means regenerated cellulose. It is a hydrophilic membrane material and is commonly considered where low nonspecific binding is desired. The relevant choice still depends on the sample matrix, analyte, pore-size objective, and qualified recovery method.
Why use a 13mm size?
A 13mm Syringe Filter can suit small-volume sample handling where a compact format is useful. It does not independently determine flow, recovery, or hold-up, so those points should be checked with the intended method. Microlab’s RC membrane product page lists 13 mm disc formats at 0.22 and 0.45 µm.
What are common applications?
Common evaluation contexts include sample clarification before chromatography, QC preparation, research workflows, and food or beverage testing. An Rc Syringe Filter may be considered for aqueous protein-containing samples, but the recovery and particulate-control requirements must be demonstrated for the actual workflow. A filtration step should be documented as a method variable, not assumed to be neutral.
What pore sizes are available?
As an RC membrane product-page specification, the stated range includes 0.1, 0.22, 0.45, 0.8, and 1.0 µm. The listed 13 mm disc formats are 0.22 and 0.45 µm. Availability in a particular syringe-filter device should be confirmed before it is specified into a method.
References
- ASTM F838-20, Standard Test Method for Determining Bacterial Retention of Membrane Filters Utilized for Liquid Filtration
- ASTM D543-21, Standard Practices for Evaluating the Resistance of Plastics to Chemical Reagents
- FDA, Sterile Drug Products Produced by Aseptic Processing — Current Good Manufacturing Practice
- Electronic Code of Federal Regulations, 21 CFR Part 211
The durable principle is straightforward: specify the filtration decision around the sample and the claim, not the label alone. When the method requires a compact format, a 13mm Syringe Filter can be part of the answer; when recovery matters, qualify the membrane and process together. For configuration discussion or sourcing support, contact Microlab Scientific and review its syringe-filter category.
To discuss an application or documentation need, contact Microlab Scientific.